Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Marlena Bütow"'
Autor:
Henrike Jacobi, Margherita Vieri, Marlena Bütow, Carolina Y. Namasu, Laura Flüter, Ivan G. Costa, Tiago Maié, Katharina Lindemann-Docter, Nicolas Chatain, Fabian Beier, Michael Huber, Wolfgang Wagner, Martina Crysandt, Tim H. Brümmendorf, Mirle Schemionek
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
The management of patients with chronic myeloid leukemia (CML) has been revolutionized by the introduction of tyrosine kinase inhibitors (TKIs), which induce deep molecular responses so that treatment can eventually be discontinued, leading to treatm
Externí odkaz:
https://doaj.org/article/1bcfdb9e48a74693a9367baef6ba229c
Autor:
Marlena Bütow, Fabio J. Testaquadra, Julian Baumeister, Tiago Maié, Nicolas Chatain, Timo Jaquet, Stefan Tillmann, Martina Crysandt, Ivan G. Costa, Tim H. Brümmendorf, Mirle Schemionek
Publikováno v:
Haematologica, Vol 108, Iss 4 (2022)
Externí odkaz:
https://doaj.org/article/812b73c5e1934e12ae3523cb4a8c88ae
Autor:
Oliver Herrmann, Maja Kim Kuepper, Marlena Bütow, Ivan G. Costa, Iris Appelmann, Fabian Beier, Tom Luedde, Till Braunschweig, Steffen Koschmieder, Tim H. Brümmendorf, Mirle Schemionek
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-14 (2019)
Abstract Background Expression of Bcr-Abl in hematopoietic stem cells is sufficient to cause chronic myeloid leukemia (CML) and tyrosine kinase inhibitors (TKI) induce molecular remission in the majority of CML patients. However, the disease driving
Externí odkaz:
https://doaj.org/article/2b700f2cbebb4287af92ed2f3c40b585
Autor:
Marlena, Bütow, Fabio J, Testaquadra, Julian, Baumeister, Tiago, Maié, Nicolas, Chatain, Timo, Jaquet, Stefan, Tillmann, Martina, Crysandt, Ivan G, Costa, Tim H, Brümmendorf, Mirle, Schemionek
Publikováno v:
Haematologica 104(4), 1179-1185 (2022). doi:10.3324/haematol.2022.280922
Haematologica (2022). doi:10.3324/haematol.2022.280922
Published by Ferrata Storti Found, Pavia
Published by Ferrata Storti Found, Pavia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f9dd6e2a821ac33f313062ac2322e48
Autor:
Till Braunschweig, Fabian Beier, Iris Appelmann, Mirle Schemionek, Oliver Herrmann, Tom Luedde, Steffen Koschmieder, Marlena Bütow, Maja Kim Kuepper, Ivan G. Costa, Tim H. Brümmendorf
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-14 (2019)
BMC cancer 19, 658 (2019). doi:10.1186/s12885-019-5871-2
BMC Cancer
BMC cancer 19, 658 (2019). doi:10.1186/s12885-019-5871-2
BMC Cancer
Background Expression of Bcr-Abl in hematopoietic stem cells is sufficient to cause chronic myeloid leukemia (CML) and tyrosine kinase inhibitors (TKI) induce molecular remission in the majority of CML patients. However, the disease driving stem cell
Autor:
Susanne Isfort, Vera Kathrin Preußger, Ralf Weiskirchen, Walter Becker, Tim H. Brümmendorf, Kim Kricheldorf, Marlena Bütow, Stefan Tillmann, Mirle Schemionek, Blanka Kubešová, Nicolas Chatain, Jörg Eschweiler, Steffen Koschmieder, Martina Wessiepe, Barbora Weinbergerova, Jiri Mayer, Kathrin Olschok, Sarah K. Schröder, Milena Kalmer, Julian Baumeister, Zdenek Racil
Publikováno v:
Cancers
Cancers, Vol 13, Iss 4210, p 4210 (2021)
Cancers 13(16), 4210 (2021). doi:10.3390/cancers13164210 special issue: "Special Issue "Pathogenesis and Natural History of Myeloproliferative Neoplasms" / Special Issue Editor: Marco Pizzi, Guest Editor"
Volume 13
Issue 16
Cancers, Vol 13, Iss 4210, p 4210 (2021)
Cancers 13(16), 4210 (2021). doi:10.3390/cancers13164210 special issue: "Special Issue "Pathogenesis and Natural History of Myeloproliferative Neoplasms" / Special Issue Editor: Marco Pizzi, Guest Editor"
Volume 13
Issue 16
Lipocalin 2 (LCN2), a proinflammatory mediator, is involved in the pathogenesis of myeloproliferative neoplasms (MPN). Here, we investigated the molecular mechanisms of LCN2 overexpression in MPN. LCN2 mRNA expression was 20-fold upregulated in perip
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35b68400919e4bc9ee410a046fcf37d1
Autor:
Christian Kaltschmidt, Holger Sudhoff, Matthias Schürmann, Johannes F. W. Greiner, Barbara Kaltschmidt, Viktoria Brotzmann, Marlena Bütow, Anna L. Höving
Publikováno v:
Stem Cell Reviews and Reports. 14:277-285
Due to their extraordinarily broad differentiation potential and persistence during adulthood, adult neural crest-derived stem cells (NCSCs) are highly promising candidates for clinical applications, particularly when facing the challenging treatment
Autor:
Michael Huber, Steffen Koschmieder, Timo Jaquet, Edgar Jost, Iris Appelmann, Marlena Bütow, Mirle Schemionek, Stefan Tillmann, Martin Kirschner, Nicolas Chatain, Tim H. Brümmendorf, Bezhad Kharabi, Christian Preisinger
Publikováno v:
Blood. 138:2246-2246
Introduction: The unfolded protein response (UPR) is a stress sensing signaling network that is activated upon endoplasmic reticulum (ER) stress, a condition characterized by an accumulation of mis- and unfolded proteins in the ER. To retain a functi
Autor:
Martin Kirschner, Gerhard Müller-Newen, Marlena Bütow, Nicolas Chatain, Tiago Maié, Tim H. Brümmendorf, Jörg Eschweiler, Ivan G. Costa, Oliver Herrmann, Angela Maurer, Janine Ziemons, Steffen Koschmieder, Maja Kim Kuepper, Mirle Schemionek
Publikováno v:
Leukemia. 33(8)
Tyrosine kinase inhibitor (TKI) therapy effectively blocks oncogenic Bcr-Abl signaling and induces molecular remission in the majority of CML patients. However, the disease-driving stem cell population is not fully targeted by TKI therapy in the majo